HGERS
RXRX icon

Householder Group Estate & Retirement Specialist’s Recursion Pharmaceuticals RXRX Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11
Closed -$110 – 1315
2024
Q1 		$110 Hold
11
– – ﹤0.01% 1228
2023
Q4 		$0 Sell
11
-400
-97% -$2.85K ﹤0.01% 1301
2023
Q3 		$3.14K Buy
+411
New +$4.1K ﹤0.01% 1008

Other funds holding RXRX

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's RXRX Position: Q2 2024 in Review

Householder Group Estate & Retirement Specialist sold out of Recursion Pharmaceuticals (RXRX) in Q2 2024, closing a stake of 11 shares — an estimated $110 sold.

Householder Group Estate & Retirement Specialist first reported a position in RXRX in Q3 2023 and held it in 3 quarters. The position peaked at $3.14K in Q3 2023. 270 funds tracked by Wall St. Rank hold RXRX as of Q2 2024.

  • Householder Group Estate & Retirement Specialist reported no remaining Recursion Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Householder Group Estate & Retirement Specialist sold 11 Recursion Pharmaceuticals shares in Q2 2024, an estimated $110.
  • Householder Group Estate & Retirement Specialist first reported a position in Recursion Pharmaceuticals in Q3 2023 and held it in 3 quarters.
  • Householder Group Estate & Retirement Specialist's Recursion Pharmaceuticals position peaked at $3.14K in Q3 2023.
  • 270 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q2 2024, filed 17 Jul 2024.